Context Therapeutics Inc. CNTX

Set alert

Price alert · CNTX

All alert types
0.19 USD -0.01 -6.25%

At close

0.20 +0.01 +5.71%

Pre-market · Nov 2, 7:29 AM ET

Bid
0.19 × 3
Ask
0.19 × 3
0.1888 Day range 0.203
0.1888 52-week range 3.62
YTD
-87.14%
1 year
-83.27%
Open
0.203
Prev close
0.2017
Mkt cap
17.37M
Vol
1.01M
Avg vol
1.53M
EPS
-0.48
P/E
0.00
Div yield
0.00%
More statistics
Low
0.1888
High
0.203
Forward P/E
-3.38
Beta
2.25
Short ratio
2.79
Inst. own
76.40%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
1.79
200-d avg
1.86
1y target
7.70

MAX chart

Chart tools
Interval

Events in this range
  • Mar 21, 2024Earnings: —; estimate -0.35; surprise —%
  • May 8, 2024Earnings: -0.23; estimate -0.38; surprise 39.47%
  • May 8, 2024Earnings: —; estimate -0.38; surprise —%
  • May 9, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • May 16, 2024Rating: Piper Sandler · — → Overweight
  • Jul 10, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Aug 7, 2024Earnings: —; estimate -0.08; surprise —%
  • Aug 7, 2024Earnings: -0.04; estimate -0.08; surprise 50%
  • Sep 16, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Sep 23, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 6, 2024Earnings: -0.22; estimate -0.11; surprise -100%
  • Nov 25, 2024Rating: D. Boral Capital · — → Buy
Signals (73)
NameDateAgo
MACD: Buy SignalOct 12, 20263 weeks ago
RSI: OversoldOct 12, 20263 weeks ago
SMA: BearishJun 1, 20265 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BullishMay 18, 20265 months ago
MACD: Sell SignalApr 13, 20266 months ago
SMA: BearishApr 6, 20267 months ago
RSI: OverboughtMar 2, 20268 months ago
RSI: OverboughtJan 26, 20269 months ago
SMA: BullishDec 15, 202510 months ago
MACD: Buy SignalDec 15, 202510 months ago
MACD: Sell SignalDec 8, 202510 months ago
SMA: BearishNov 17, 202511 months ago
SMA: BullishAug 11, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BullishJul 14, 20251 year ago
SMA: BullishJul 7, 20251 year ago
SMA: BearishMay 12, 20251 year ago
MACD: Buy SignalApr 14, 20251 year ago
SMA: BullishApr 7, 20251 year ago
SMA: BearishNov 4, 20241 year ago
SMA: BearishNov 4, 20241 year ago
SMA: BullishOct 21, 20242 years ago
SMA: BearishSep 23, 20242 years ago
SMA: BearishSep 9, 20242 years ago
MACD: Sell SignalSep 9, 20242 years ago
SMA: BullishJul 8, 20242 years ago
SMA: BearishJul 1, 20242 years ago
RSI: OverboughtMay 13, 20242 years ago
SMA: BullishMar 18, 20242 years ago
SMA: BearishMar 11, 20242 years ago
SMA: BullishFeb 19, 20242 years ago
SMA: BullishFeb 19, 20242 years ago
MACD: Buy SignalFeb 19, 20242 years ago
SMA: BearishJan 22, 20242 years ago
MACD: Sell SignalJan 22, 20242 years ago
SMA: BullishJan 1, 20242 years ago
MACD: Buy SignalJan 1, 20242 years ago
SMA: BullishDec 18, 20232 years ago
SMA: BearishNov 6, 20232 years ago
SMA: BearishNov 6, 20232 years ago
MACD: Sell SignalNov 6, 20232 years ago
SMA: BullishOct 30, 20233 years ago
SMA: BullishOct 30, 20233 years ago
MACD: Buy SignalOct 30, 20233 years ago
SMA: BearishOct 23, 20233 years ago
SMA: BearishOct 23, 20233 years ago
MACD: Sell SignalOct 23, 20233 years ago
SMA: BullishSep 25, 20233 years ago
MACD: Buy SignalSep 25, 20233 years ago
SMA: BullishSep 11, 20233 years ago
SMA: BearishSep 4, 20233 years ago
MACD: Sell SignalAug 21, 20233 years ago
SMA: BearishJul 17, 20233 years ago
RSI: OverboughtJun 26, 20233 years ago
SMA: BullishMay 22, 20233 years ago
SMA: BullishMay 15, 20233 years ago
SMA: BearishFeb 27, 20233 years ago
SMA: BullishJan 30, 20233 years ago
MACD: Buy SignalJan 23, 20233 years ago
MACD: Sell SignalDec 19, 20223 years ago
SMA: BearishDec 5, 20223 years ago
RSI: OversoldDec 5, 20223 years ago
SMA: BullishNov 14, 20223 years ago
MACD: Buy SignalOct 31, 20224 years ago
MACD: Sell SignalOct 3, 20224 years ago
RSI: OversoldSep 12, 20224 years ago
SMA: BearishAug 15, 20224 years ago
SMA: BullishAug 8, 20224 years ago
SMA: BearishJul 18, 20224 years ago
SMA: BullishMay 23, 20224 years ago
SMA: BearishApr 11, 20224 years ago
SMA: BullishMar 14, 20224 years ago

Financial health

Altman Z-Score

-5.67 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -3.9×
FY 2019: -7.5×FY 2020: 51.0×FY 2021: -0.7×FY 2022: -0.7×FY 2023: -0.8×FY 2024: -2.3×FY 2025: -3.9×
FY 2019 5y median -0.8× FY 2025
P/S 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 2.3×
FY 2019: -2.3×FY 2020: -3.3×FY 2021: 0.2×FY 2022: 0.3×FY 2023: 1.5×FY 2024: 0.6×FY 2025: 2.3×
FY 2019 5y median 0.6× FY 2025
P/FCF -5.3×
FY 2019: -19.7×FY 2020: -54.0×FY 2021: -0.8×FY 2022: -0.7×FY 2023: -0.9×FY 2024: -2.1×FY 2025: -5.3×
FY 2019 5y median -0.9× FY 2025
EV/EBITDA -2.1×
FY 2019: -14.4×FY 2020: -23.9×FY 2021: 4.0×FY 2022: 1.7×FY 2023: -0.1×FY 2024: 1.2×FY 2025: -2.1×
FY 2019 5y median 1.2× FY 2025
EV/Sales 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -18.9%
FY 2019: -5.1%FY 2020: -1.9%FY 2021: -120.0%FY 2022: -135.4%FY 2023: -116.7%FY 2024: -47.8%FY 2025: -18.9%
FY 2019 5y median -116.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -59.7%
FY 2019: 26.6%FY 2020: -39.3%FY 2021: -21.7%FY 2022: -42.7%FY 2023: -201.9%FY 2024: -28.1%FY 2025: -59.7%
FY 2019 5y median -42.7% FY 2025
ROIC -65.5%
FY 2019: 270.0%FY 2020: 80.5%FY 2021: -21.8%FY 2022: -44.2%FY 2023: -211.2%FY 2024: -31.3%FY 2025: -65.5%
FY 2019 5y median -44.2% FY 2025
ROA -52.7%
FY 2019: -2333.8%FY 2020: 1421.7%FY 2021: -20.4%FY 2022: -39.1%FY 2023: -149.2%FY 2024: -27.2%FY 2025: -52.7%
FY 2019 5y median -39.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 FY 2025
Operating Income -32.7%
FY 2019: 0.0%FY 2020: 52.2%FY 2021: -309.2%FY 2022: -46.1%FY 2023: -63.0%FY 2024: -19.3%FY 2025: -32.7%
FY 2019 FY 2025
EPS (diluted) 17.4%
FY 2019: 0.0%FY 2020: 114.7%FY 2021: -3790.0%FY 2022: 74.8%FY 2023: -61.3%FY 2024: 69.3%FY 2025: 17.4%
FY 2019 FY 2025
Free Cash Flow 9.9%
FY 2019: 0.0%FY 2020: 63.5%FY 2021: -774.7%FY 2022: -55.7%FY 2023: -49.4%FY 2024: -39.3%FY 2025: 9.9%
FY 2019 FY 2025

Financial Health

Current Ratio 8.5×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 16.9×FY 2022: 11.8×FY 2023: 3.8×FY 2024: 35.6×FY 2025: 8.5×
FY 2019 5y median 11.8× FY 2025
Quick Ratio 8.5×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 16.9×FY 2022: 11.8×FY 2023: 3.8×FY 2024: 35.6×FY 2025: 8.5×
FY 2019 5y median 11.8× FY 2025
Debt / Equity 0.0×
FY 2019: -0.9×FY 2020: -0.4×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.8×
FY 2019: -4.0×FY 2020: -2.2×FY 2021: 4.7×FY 2022: 2.4×FY 2023: 0.6×FY 2024: 3.5×FY 2025: 1.8×
FY 2019 5y median 2.4× FY 2025
Interest Coverage 0.0×
FY 2019: -4.9×FY 2020: -3.9×FY 2021: -164×FY 2022: -28.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31